Product Image

Boswellia Extract 500 mg

NOW
4.7
★ ★ ★ ★ ★
(11666 ratings)
Boswellia 500 mg
Product Image
Score81
A large, economical softgel serving is attractive, but exact boswellic-acid potency remains unknown.
How scoring works
Quantity:90 Softgel(s) • (90 servings)
Goals:
Joint Health
Anti-Inflammatory Support

Score 81

A large, economical softgel serving is attractive, but exact boswellic-acid potency remains unknown.
How scoring works
$13.99($0.15 per serving)
Pure Formulas
$ 17.30
Vitacost
$ 19.75
Daily Vita
$ 17.40
Amazon
$ 13.99
iHerb
$ 18.36
Report prices

Analysis

The 500 mg Boswellia extract serving is large enough to be meaningful for a concentrated product. Its single-active design stays focused on joint comfort and inflammatory balance.

A softgel with a small amount of fat may improve delivery compared with a dry capsule. The label references boswellic and organic acids without quantifying them, so the active dose cannot be matched to well-characterized extracts.

One softgel per serving and a very low ongoing cost create good practical value. It suits buyers who prioritize dose, format, and affordability over verified marker standardization.

Who is it for
  • Adults seeking an affordable Boswellia softgel
  • People who prefer one unit per serving
  • Users prioritizing total extract amount
Best for
  • Budget-friendly joint-comfort support
  • Lipid-based Boswellia delivery
  • Simple daily supplementation

Pros

  • Substantial 500 mg extract amount
  • Fat-containing softgel may aid absorption
  • Very favorable ongoing cost

Cons

  • Boswellic-acid percentage is not stated
  • No quantified AKBA
  • Duplicate extract descriptors are not explained

Warnings

  • Boswellia may cause stomach upset, reflux, or loose stools.
  • Boswellia may add to anticoagulant or antiplatelet effects.
  • Confirm the softgel shell source if avoiding animal-derived gelatin.

Nutrient quality

86 Highest impact

A substantial Boswellia amount and lipid softgel support useful delivery. Missing active-acid percentages and AKBA yield limit potency assurance.

.

Ingredient transparency

75 High impact

The total extract amount is disclosed without a hidden blend. Repeated marker entries, intake directions, and inactive ingredients remain incomplete.

.

Customer satisfaction

72 High impact

The supplied average rating is strong and comes from a very large rating pool. No firsthand experiences or recurring complaint details were provided, so consistency remains uncertain.

.

Value for money

94 Highest impact

A substantial softgel dose and low serving cost create strong value. Missing active-acid percentages are the main quality limitation.

.
Report analysis

Goals

Joint Health
Impact
High effect
A- Goal FitB+ Strength of SupportD CoverageA+ Formula Quality
Boswellia · 500 mg

Boswellia directly modulates inflammatory pathways involved in joint discomfort and may support mobility. The 500 mg extract amount is substantial and delivered in a fat-containing softgel.

The label mentions boswellic acids without giving their percentage or AKBA yield, so clinical potency cannot be confirmed. The focused formula does not supply cartilage building blocks or lubrication support.

Study evidence
Boswellia Supportive 24 studies
Anti-Inflammatory Support
Impact
High effect
A Goal FitB- Strength of SupportD+ CoverageA- Formula Quality
Boswellia · 500 mg

Boswellia directly targets the 5-LOX inflammatory pathway and closely fits the selected goal. Human evidence supports standardized boswellia for inflammatory discomfort, though potency depends on boswellic-acid content.

The 500 mg extract amount reaches a meaningful range for a concentrated boswellia product. The total extract amount is clear, but the boswellic-acid percentage and extract ratio are not provided.

Study evidence
Boswellia Supportive 19 studies

Ingredients

IngredientAmount per serving
Calories
5 Calorie(s)
Total Fat
0.5 Gram(s)
Boswellia extract (Boswellic Acid, organic Acids)
500 mg
Gluten Free Adults 18–50 Kosher Dairy Free
Report overview
F Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyB- Value

The full-size Boswellia extract serving is delivered in a softgel, which may help absorption. However, the label does not quantify total boswellic acids or AKBA, leaving potency uncertain. The very low cost partly offsets the missing standardization and supports good value.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsJoint Health Anti-Inflammatory Support forBoswellia
  2. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsAnti-Inflammatory Support Joint Health forBoswellia
  3. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  4. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsAnti-Inflammatory Support forBoswellia
  5. Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities.
    Efferth T; Oesch F · Seminars in cancer biology · 2022
    Systematic reviewAnti-Inflammatory Support forBoswellia
  6. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsJoint Health Anti-Inflammatory Support forBoswellia
  7. Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis.
    Zhang Y; Gui Y; Adams R; Farragher J; Itsiopoulos C; Bow K; Cai M; Han J · Nutrients · 2025
    Meta-analysis4,599 participants39 studies pooledJoint Health forBoswellia
  8. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health Anti-Inflammatory Support forBoswellia
  9. A full-spectrum Boswellia serrata extract with enhanced bioavailability, and its co-delivered system with curcumin alleviate pain and stiffness associated with moderate spondylitis: a randomized double-blind, placebo-controlled, 3-arm study.
    Mamatha K; Prabhakaran P; Syam Das S; Kanjoormana Aryan M; Thomas J · Frontiers in pharmacology · 2025
    Randomized trial105 participantsAnti-Inflammatory Support forBoswellia
  10. Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study.
    Sengupta K; Krishnaraju AV; Vishal AA; Mishra A; Trimurtulu G; Sarma KV; Raychaudhuri SK; Raychaudhuri SP · International journal of medical sciences · 2011
    Randomized trial60 participantsJoint Health forBoswellia
  11. Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis.
    Bannuru RR; Osani MC; Al-Eid F; Wang C · Seminars in arthritis and rheumatism · 2019
    Meta-analysis1,009 participants11 studies pooledJoint Health forBoswellia
  12. Efficacy and Safety of Aflapin®, a Novel Boswellia Serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study.
    Karlapudi V; Sunkara KB; Konda PR; Sarma KV; Rokkam MP · Journal of the American Nutrition Association · 2023
    Randomized trial70 participantsJoint Health forBoswellia
  13. Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis.
    Dalmonte T; Andreani G; Rudelli C; Isani G · Phytotherapy research : PTR · 2024
    Meta-analysis1,185 participants13 studies pooledJoint Health forBoswellia
  14. Double-blind trial of solid lipid Boswellia serrata particles (SLBSP) vs. standardized Boswellia serrata gum extract (BSE) for osteoarthritis of knee.
    Kulkarni PD; Damle ND; Singh S; Yadav KS; Ghante MR; Bhaskar VH; Hingorani L; Gota VS · Drug metabolism and personalized therapy · 2021
    Randomized trialAnti-Inflammatory Support forBoswellia
  15. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsAnti-Inflammatory Support forBoswellia
  16. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy.
    Holtmeier W; Zeuzem S; Preiss J; Kruis W; Böhm S; Maaser C; Raedler A; Schmidt C; Schnitker J; Schwarz J; Zeitz M; Caspary W · Inflammatory bowel diseases · 2011
    Randomized trial108 participantsAnti-Inflammatory Support forBoswellia
  17. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia